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ABSTRACT 
              Alzheimer’s disease is a progressive neurodegenerative disorder characterized by 
gradual decline in memory. The present study was undertaken to investigate the memory 
strengthening effect of Abelmoschus moschatus Medic. Ethanolic extract of seeds   
(100,200mg/kg. p.o) was administered for 7 successive days to young mice. Exteroceptive 
behavioral model such as elevated plus maze was employed to evaluate learning and memory. 
To delineate the mechanism by which AM exerts memory strengthening activity, the effect of 
AM on whole brain AchE, Brain Malondialdehyde content , Reduced Glutathione were also 
assessed. Piracetam (200mg/kg, i.p) was used as a standard drug.  Pretreatment with AM 
(200,400mg, p.o) for seven successive days significantly improved learning and memory in mice 
and reversed the amnesia induced by diazepam (1mg/kg, i.p). AM also decreased whole brain 
AchE and Malondialdehyde content and increase the brain reduced glutathione. Hence 
Abelmoschus moschatus Medic. appears to be a promising candidate for improving memory, 
Anti cholinesterase activity and Anti oxidant property and it would be worthwhile to explore the 
potential of this plant in the management of dementia and Alzheimer’s disease.  
Key words: Abelmoschus moschatus, Alzheimer’s disease, elevated plus maze model, Anti 
cholinergic. 
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1. INTRODUCTION 
 Memory is the ability of an individual to record sensory stimuli, events, information etc., 
retain them over short or long periods of time and recall the same at a later date when needed. 
Poor memory, lower retention and slow recall are common problems in today’s stressful and 
competitive world. Age, stress and emotions are conditions that may lead to memory loss 
(1)
        
  It is the process in which information is encoded, stored and retrieved. Encoding allows 
information that is from the outside world to reach our senses in the forms of chemical and 
physical stimuli. In this first stage we must change the information so that we may put the 
memory into the encoding process. Storage is the second memory stage or process. This entails 
that we maintain information over periods of time. Finally third process is the retrieval of 
information that we have stored. We must locate it and return it to our consciousness. 
 Human body is interconnected and is designed to perform many activities at the same 
time. Human memory is very crucial in predicting the daily routine performance. 
 There are many factors that determine the performance of human memory. A set of 
diseases affects the performance of the human brain are called as the memory related diseases or 
neurodegenerative diseases 
(2), One of the diseases is the Alzheimer’s disease (AD) and that is 
much like the dementia, is characterized by the development of senile plaques and neurofibrillary 
tangles, which are associated with neuronal loss affecting to a greater extent cholinergic neurons 
in brain. 
 The disease progresses with the passage of time and as a person get older the disease also 
matures. Around 35 million patients suffer from Alzheimer’s disease all over the world and this 
number is increasing with each passing second 
(3)
.  
  An epidemiological study reveals that dementia is largely hidden problem, especially in 
rapidly developing and heavily populated regions such as India, China and America 
(3)
. Dementia 
associated with Alzheimer’s disease is the most common cause of memory impairment or 
cognitive disability in elderly people. 
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ALZHEIMER’S COMMON WARNING SIGNS (4, 5) 
             Alzheimer is a disease which affects our memory and thinking capabilities. In its initial 
stages it affects our memory, but in later this cause adverse effects on daily life routine. Beware 
of the disease and consider various symptoms to stop the problem. It has some specific and clear 
symptoms in its initial stages like, 
 The first most common sign is the memory loss. You may forget dates and events and 
then recall them latter. This state of forgetting things may be an initial sign of the brain 
disease. 
 
 People start facing a problem in solving matters and daily plans and they may not be able 
to handle numbers and checkbooks to figure out the calculation. The challenges they face 
may be a warning sign of the growing Alzheimer’s. 
 
 People start facing problems in handling their daily home tasks. They even find difficult 
in recording programs and memorizing rules of the games. 
 
 In some middle stages people face this problem and the warning sign is the time and 
place loss. They cannot recognize where they are and how much time has been passed. 
 
 This brain disease also affects chromatic vision. They will not be recognizing colour and 
visual picture due to the effect of brain. 
 
 One warning sign of Alzheimer’s is forgetting words and spellings. People may not 
continue their speech and forgets what to speak later on. Difficulty in speaking and 
making words with letters is also a sign of disease. 
 
 Other symptoms of the disease include leaving social activities and gathering, facing 
difficulties in decision making and talking with other people. 
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CAUSES FOR MEMORY LOSS 
(6, 7)
 
 Medications: A number of prescription and over-the-counter medications can interfere 
with or cause loss of memory. Possible culprits include: antidepressants, antihistamines, 
anti-anxiety medications, muscle relaxants, tranquilizers, sleeping pills, and pain 
medications given after surgery. 
 Alcohol, tobacco or drug use: Excessive alcohol use has long been recognized as a 
cause of memory loss. Smoking harms memory by reducing the amount of oxygen that 
goes to the brain. Studies have shown that people who smoke find it more difficult to put 
faces with names than do nonsmokers. Illicit drugs can change chemicals in the brain 
that can make it hard to recall memories. 
 Sleep deprivation: Both quantity and quality of sleep are important to memory. Getting 
too little sleep or waking frequently in the night can lead to fatigue, which interferes with 
the ability to consolidate and retrieve information. 
 Depression and stress: Being depressed can make it difficult to pay attention and focus, 
which can affect memory. Stress and anxiety can also get in the way of concentration. 
When you are tense and your mind is over stimulated or distracted, your ability to 
remember can suffer. Stress caused by an emotional trauma can also lead to memory 
loss. 
 Nutritional deficiency: Good nutrition, including high-quality proteins and fats are 
important for proper brain function. Deficiencies in vitamin B1 and B12 specifically can 
affect memory. 
 Head injury: A severe hit to the head, from a fall or automobile accident, can injure the 
brain and cause both short- and long-term memory loss. Memory may gradually improve 
over time. 
 Stroke: A stroke occurs when the blood supply to the brain is stopped due to the 
blockage of a blood vessel to the brain or leakage of a vessel into the brain. Strokes often 
cause short-term memory loss. A person who has had a stroke may have vivid memories 
of childhood events but be unable to recall what he or she had for lunch. 
 Dementia: Dementia is the name for progressive loss of memory and other aspects of 
thinking that are severe enough to interfere with the ability to function in daily activities. 
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Although there are many causes of dementia, including blood vessel disease, drug or 
alcohol abuse, or other causes of damage to the brain, the most common and familiar is 
Alzheimer's disease. Alzheimer's disease is characterized by a progressive loss of brain 
cells and other irregularities of the brain. 
 Other causes: Other possible causes of memory loss include an underactive or 
overactive thyroid gland and infections such as HIV, tuberculosis, and syphilis that 
affects the brain. 
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ANATOMY OF BRAIN 
(8)
 
 Brain is the most complex of all organs.  It hears, sees, feels, tastes, commands the limbs, 
talks, reads, writes, makes decisions and accomplishes numerous other functions.  Most 
importantly for our interests, it is the organ of memory.  
 Our ears may hear the concert; our eyes may see the famous painting; our fingers may 
feel the silk nightgown; our nose may smell, our mouth may taste that delicious chocolate, but 
only our brain remembers what the experience was like, where it happened and the numerous 
other details involved. So, although the sensory abilities described above are not typically 
affected by Alzheimer’s disease, the memory of these experiences and perhaps the appreciation 
of them can be markedly affected. 
 
 Figure 1 Anatomy of brain 
INTRODUCTION 
 
Department Of Pharmacognosy, MMC, Chennai-03. Page 6 
 
 Our brain is divided into right and left halves. The left half controls movement on the 
body’s right side, the right half controls the body’s left side. 
THREE PARTS, THREE POUNDS  
 
 
                    Figure 2.Parts of the brain 
 Our brain is our most powerful organ, yet weighs only about three pounds. It has a 
texture similar to firm jelly. 
 It has three main parts  
 The cerebrum fills up most of our skull. It is involved in remembering, problem solving 
and feeling. It also controls movement. The wrinkled surface is a specialized outer layer 
of the cerebrum called the cortex. 
            Specific regions of cortex: 
1. Interpret sensations from our body and sights, sounds and smells from the outside 
world. 
2. Generate thoughts, solve problems and make plans, form and store memories, control 
voluntary movement. 
 The cerebellum sits at the back of our head, under the cerebrum. It controls coordination 
and balance. 
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 The brain stem sits beneath our cerebrum in front of our cerebellum. It connects the 
brain to the spinal cord and controls automatic functions such as breathing, digestion, 
heart rate and blood pressure. 
 Our brain is nourished by one of our body’s richest networks of blood vessels. With each 
heartbeat, arteries carry about 20 to 25% of our blood to our brain, where billions of cells 
use about 20% of the oxygen and fuel our blood carries. 
THE NEURON FOREST AND CELL SIGNALING 
 
 
           Figures 3. The neuron forest and cell signaling 
 An adult brain contains about 100 billion nerve cells or neurons with branches that 
connect at more than 100 trillion points are called as “neuron forest”. 
 Signals travelling through the neuron forest form the basis of memories, thoughts and 
feelings. Neurons are the chief type of cell destroyed by Alzheimer’s disease. 
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 Signals that form memories and thoughts move through an individual nerve cell as a tiny 
electrical charge. Nerve cells connect to one another at synapses. When a charge reaches 
a synapse, it may trigger release of tiny bursts of chemicals called neurotransmitters. The 
neurotransmitters travel across the synapse; carrying signals to other cells, scientists have 
identified dozens of neurotransmitters. 
 Alzheimer’s disease disrupts both the way electrical charges travel within cells and the 
activity of neurotransmitters.   
ALZHEIMER’S CHANGES THE WHOLE BRAIN                       
 
         Figure 4.Alzheimer’s changes the whole brain 
 Alzheimer’s disease leads to nerve cell death and tissue loss throughout the brain. Over 
time, the brain shrinks dramatically, affecting nearly all its functions.  
             Reducing oxidative stress by antioxidants, protecting brain inflammatory lesions using 
anti inflammatory drugs and facilitation of brain cholinergic neurotransmission with anti 
cholinesterase are some positive approach to management of AD
(4) . 
Due to increase incidence of 
side effects of allopathic medicine (both nootropic and cholinesterase inhibitors) more research 
will be manifested towards the use of natural resources like medicinal plants for the management 
of various cognitive disorders.  
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            The nature provides a new opportunity to regain one’s full mental capacity. A number of 
herbs traditionally employed in the Indian system of medicine “Ayurveda” have yielded positive 
results. 
HERBAL MEDICINE 
(9, 10)
 
                    Plants have been one of the important sources of medicine ever since the dawn of 
human civilization. In spite of tremendous developments in the field of allopathy, herbs are 
staging a comeback and “Herbal Renaissance” is happening all over the globe.  
                       Even as we enter into the new century with its existing prospect of gene therapy, 
herbal medicines remain one of the common forms of therapy available to the world population. 
The acceptance and recognition of the herbal medicine has been in part due to the 
acknowledgement of the value of traditional medicine in Indigenous Pharmacopoeias, the 
incorporation of some medicines derived from these sources into Pharmaceuticals, the need to 
make health care affordable to all and the perception that pharmaceutical drugs are expensive 
and have more side effects. Another important perception fomenting this interest is that natural 
remedies are somehow safer and more efficacious than remedies that are pharmaceutically 
derived.    
IMPORTANCE OF HERBAL MEDICINE 
                   According to WHO (2001) 60% of the world’s population depend on traditional 
medicine and 80% of the population in developing countries depend almost entirely on 
traditional medical practices, in particular herbal medicine for their primary healthcare needs. 
                  As for developed countries, it is reported that sufferers of chronic diseases are turning 
to herbal remedies as alternatives to modern synthetic drugs. This renewed interest in the use of 
herbal medicine is to be motivated by several factors such as side effects of modern drugs, the 
effectiveness of plant remedies and high cost of synthetic drugs. The use of and search for drugs 
and dietary supplements derived from plants have accelerated in recent years.    
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Table 1.Herbals used for treatment of memory disorders 
(11-16)
 
S.No Biological name Synonym Active constituents 
 
1. Baccopa monnieri Brahmi Triterpene glycoside 
2. Valriana wallichi Tagara Flavones glycoside 
3. Nardostachys jatamansi Jatamansi Flavonoids 
4. Withania somnifera Ashwaganda Withenolides 
5. Terminalia arjuna Arjuna Alkaloids 
6. Piper longum Pippali moola Alkaloids 
7. Myristica fragrance Jatiphala Volatile oil 
8. Acorous calamus Vacha Phenolic compounds 
9. Rauwolfia serpentine Sarpagandha Alkaloids 
10. Celastrus paniculatus Jyothismati Volatile oil. 
 
Drug used for Alzheimer’s which contain isolated plant constituents (17-19) 
 Huperizine A is an alkaloid with a potent acetyl cholinesterase inhibitory activity isolated 
from the Chinese club moss Huperzia serrata. Huperizine A is currently available in the USA as 
“Nutraceuticals” or “functional food”. 
 Galantamine is an alkaloid used for symptomatic treatment of patients with early onset 
Alzheimer’s disease. It was initially isolated from the snowdrop (Galanthus woronowii) in the 
early 1950’s and has since been found in other plants in the family Amaryllidaceae. Galantamine 
slows the process of neurological degeneration by inhibiting AchE. Due to the limited 
availability of the plants of origin of this compound, Galantamine is now produced by total 
synthesis. 
 Considering the importance of herbal medicine in memory strengthening activity, the 
present study was aimed to investigate the effects of Abelmoschus moschatus plant on memory 
strengthening and brain cholinesterase activity in mice. 
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2. REVIEW OF LITERATURE 
Pharmacognostical Review: 
1. Ilaria Molfetta, Lucia Ceccarini, Mario Macchia, Guido Flamini, Pierluigi Cioni (2013) 
investigated Abelmoschus esculentus and Abelmoschus moschatus seeds production and 
analysis of the volatile compounds.
(22)
 
2. Dubey Kumara Priyanka and Datta K.Animesh (2012) investigated induced Mutagenesis 
in Abelmoschus moschatus Medic.
(23)
 
3. Asish R. Warghat, Nandkishor H. Ram Pure and Prashant Wagh, (2011) evaluated the in 
vitro callus induction of Abelmoschus moschatus Medic., by using different hormone 
concentration and they reported that the good callus induction was found in MS medium 
supplemented with 0.3mg/1BAP and 2mg/NAA from first leaf explants.
(24)
 
Phytochemical review: 
1. AJM. Christina, P.Muthumani (2012) reported the Phytochemical studies on leaves of 
Abelmoschus moschatus Medic.
(25)
 
Pharmacological review: 
1. AJM. Christina, P.Muthumani (2013) investigated the protective effect of the hydro 
alcoholic extract of Abelmoschus moschatus Medic., against Ethylene glycol induced 
Urolithiasis and it’s possible underlying Mechanism using Male Wistar Albino Rats.(25) 
2. AJM.Christina, P.Muthumani (2012) reported the Abelmoschus moschatus whole plant 
exhibited significant diuretic activity as evidenced by increase in total urine volume and 
the urine concentration of sodium, potassium and chloride.
(26)
 
3. Abishek Kumar Singh, Sanjiv Singh, H.S. Chandel (2012) Evaluated the Hepato 
protective activity of Abelmoschus moschatus seed extract against Paracetamol and 
Ethanol induced hepato toxicity.
(27)
 
4. RU Li, Changdong wang, Tao Chen, Peng Chen (2012) reported quantitative proteomic 
analysis of cold-responsive proteins in Abelmoschus Moschatus.
(28)
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5. Mir ZGul, Lapakshi M Bhakshu, Farhan ahmad, Anand K Kondapi (2011) evaluated that 
the seed and leaf extract of Abelmoschus moschatus Medic., possess significant Anti 
oxidant Activity, Moderate Anti Bacterial activity, Anti proliferative activity against two 
human cancer cell lines.
(29)
 
6. Priti Maheshwari, Anil Kumar (2009) reported the Anti Microbial activity of 
Abelmoschus moschatus Leaf Extract.
(30)
 
7. Liu IM, Tzeng IT, Liou SS, Lan TW (2007) evaluated the improvement of insulin 
sensitivity in obese Zucker rats by Myricetin extracted from Abelmoschus moschatus 
Medic.,
(31)
 
8. D.Sahoo, K.S Jena, P K Rout and T.R.Rao (2003) investigated two stage solvent 
extraction of seeds of Hibiscus abelmoschus Medic.
(32)
 
9. G.Ramu, G Krishna Mohan, KN Jayaveera, N Suresh, Chandra Prakash(2002) reported 
that Seed starch obtained from Abelmoschus moschatus was employed as a disintegrant 
to paracetamol tablets at concentration of 2.5-10.0%w/w.
(33)
 
10. R.Pandey, A Kalra, N Katiyar, S Kumar (2001), Nematicidal activity in flowers of 
Abelmoschus moschatus and aromatic plants.
(34)
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3. AIM AND OBJECTIVE OF THE STUDY 
 Poor memory, lower retention and slow recall are common problems in today’s stressful 
and competitive world. Age, stress and emotions are conditions that may lead to memory loss. A 
set of diseases are there which affects the performance of human brain like Alzheimer’s disease. 
AD is a life threatening disorder with increasing incidence throughout the world. 
 Many traditional plants were successfully used for the treatment of memory loss. Though 
the active principle of various classes of chemical compounds has been isolated from plants, 
some remain to be identified. 
 Nowadays, the use of complementary and alternative medicine and especially the 
consumption of botanicals have been increasing rapidly worldwide, mostly because of the 
supposedly less frequent side effects when compared to modern western medicine. 
  Abelmoschus moschatus Medic is a folk medicinal shrub known as Kattukasthuri. In the 
present study an attempt was made to investigate the Pharmacognostical, Phytochemical 
screening and Memory Strengthening activity on the Seeds of Abelmoschus moschatus Medic. 
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4. RATIONALE FOR SELECTION OF THE PLANT 
 Now a day’s many plants are being upgraded by validating traditional claims and 
establishing its medicinal value. Various plants are yet to be scientifically proven for their 
therapeutic efficacy. 
 Abelmoschus moschatus Medic. is one such fascinating shrub belonging to the family 
Malvaceae. This plant is commonly known as musk mallow, Musk recognized by the musk-
scented seeds. 
 The plant has a long history of numerous traditional and ethno botanical applications in 
diverse cultures. Many tribes considered it has a cure for all ailments. Leaves are used for 
gonorrhea; roots are used in renal disorders, diuretic, anti spasmodic. In Egypt, seeds are chewed 
to relieve stomach problems, Infusion, decoction or tincture of seeds used for nervous debility, 
hysteria and other nervous disorders. Traditionally seeds have been used for treatment of neuro 
degenerative disorders. 
(20, 21)
 The present study was undertaken to investigate the effects of 
Abelmoschus moschatus Medic. on memory strengthening activity. 
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5. ETHNO BOTANICAL SURVEY 
PLANT PROFILE 
(20)
 
Plant name                 : Abelmoschus moschatus Medic. 
Common name           : Musk mallow 
Tamil name                : Kattukkasturi 
Family                        : Malvaceae 
TAXONOMICAL STATUS 
Kingdom   :   Plantae (plants) 
Division     :  Magnoliopsida (flowering agent) 
Order         :   Malvales 
Family       :   Malvaceae 
Genus        :  Abelmoschus 
Species      :   moschatus   
Habitate 
              Throughout the Philippines and India. In India the plant is grown widely over the 
Deccan regions, the hilly regions of Karnataka and at the foothills of the Himalayas. 
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Abelmoschus moschatus Medic. 
 
  Figure 5.Whole plant of Abelmoschus moschatus 
Seeds of Abelmoschus moschatus Medic. 
 
Figure 6. Seeds of Abelmoschus moschatus 
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PLANT DISTRIBUTION 
(21)
 
 Kattukasthuri is an annual, erect and branched herb, about a meter high or less, covered 
with very long hairs. 
DESCRIPTION: 
 It is annual or biennial, erect herb or under shrub, 0.5-3.5 m tall, hispid, often woody at 
base with taproot or tuberous root.  
Stems : Stem usually solid, sometimes hollow, stem apices and petioles with many obliquely 
downwardly directed long sharp bristles, rarely sparsely hairy or glabrous. 
Leaves : Alternate, extremely variable in shape and size, petiole 6-30 cm long, stipules linear-
filiform, simply hairy, lower leaves are orbicular to transversely elliptical in outline, 6-22cm × 8-
24cm, base cordate, angular or 3-7 palmately lobed or parted, higher leaves usually narrower and 
often hastate or sagittate, oblong-lanceolate. 
Stipules  : Linear to filiform, simply hairy. 
Flowers  : Bright yellow and large flowers are usually solitary and auxiliary. Epicalyx segments 
7-10 rarely more, persistent and linear with simple hairs. Petals obovate, at apex rounded, at base 
fleshy and ciliate by simple hairs. 
Capsule : 5-8cm long, ovoid or globose, occasionally fusiform, somewhat angular, usually 
hispid by simple, stiff hairs, rarely glabrous, black or dark brown in colour. 
Seeds    : concentrically ribbed, sub-reniform , mostly glabrous, musky scented, black to brown 
in colour. 
ETHANOBOTANICAL USES 
(20)
 
 Decoction of pounded seed used as a diuretic, tonic and carminatie. 
 Mucilagenous decoction of root and leaves used for gonorrhea. 
 Seeds used as antihysteric. 
 In Malaya, leaves and roots used as poultice. 
 Used for headaches, rheumatism, varicose veins, cystits and fever. 
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 In Java, powder or infusion of roots used to stimulate the kidneys and intestines. 
 In the West Indies, seeds are used as antispasmodic. 
 Infusion,decoction or tincture of seeds used for nervous debilty, hysteria and other 
nervous disorders. 
 In the Carribean, seeds are used for female reproductive problems and for childbirth. 
 In Egypt, seeds are chewed to releive stomach problems, to sooth nerves and “sweeten” 
the breath,also considered as an aphrodisiac. 
 In Ayurveda, plant considered to pacify aggravated pitta, kapha, bonchitis, asthuma, 
dyspepsia, coli, calcli, diarrhoea, flatulence, vomiting, nervous sysytem disorders. 
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6. PLAN OF WORK 
I. PHARMACOGNOSTICAL STUDIES 
 Collection of plant material 
 Authentication 
 Macroscopy 
 Microscopy 
 Powder microscopy 
 Physiochemical constants 
 Qualitative analysis of heavy metals and inorganic elements 
 Quantitative estimation of heavy metals and inorganic elements. 
 
II. PHYTOCHEMICAL STUDIES 
 Preparation of extracts 
 Preliminary Phytochemical screening of powder and extracts 
 Fluorescence analysis of powder and extracts 
 Quantitative estimation of phytoconstituents. 
 Thin layer chromatography. 
 High Performance Thin Layer Chromatography. 
 
III. SELECTION OF ACTIVE EXTRACT BASED ON IN VITRO ANTI-OXIDANT       
STUDIES 
 Reducing power Assay 
 Hydrogen peroxide scavenging Assay. 
 
  IV. PHARMACOLOGICAL STUDIES 
  Memory strengthening activity 
 Effect on Transfer Latency  
 Estimation of Brain AchE level. 
  In vivo Anti oxidant studies 
 Estimation of Brain Malondialdehyde Level. 
 Estimation of Brain Reduced Glutathione Level. 
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7. METHODOLOGY 
7.1 PHARMACOGNOSTICAL STUDIES 
(35)
 
 Evaluation of a drug means confirmation of its identity, determination of its quality and 
purity and detection of nature of adulteration. Evaluation of a crude drug can be attempted by 
different methods which include morphological and microscopical studies of the crude drugs or 
their physical, chemical and biological behavior. Systematic identification of crude drugs and 
their quality assurance gives an integral part of drug description. 
 Pharmacognostical studies basically deals with the identification, authentication and 
standardization of herbal medicinal plants through organoleptic character, histological character, 
powder microscopy, quantitative microscopy, histochemical analysis and physio chemical 
observations as prescribed by an authoritative source such as World Health Organization 
(WHO). 
Plant collection and Authentication  
 The fresh seeds of the plant Abelmoschus moschatus Medic. was collected from 
Palayamkottai in Tirunelveli Dist, Tamilnadu, India. It was identified and authenticated by the 
Botanist V.Chelladurai, Research Officer, Botany (Scientist-C), Govt. Council for Research in 
Ayurveda and Siddha, Govt of India (Retired). 
MACROSCOPY  
 Macroscopical character includes organoleptic characters and morphological features of 
the plant were studied. 
MICROSCOPY 
(36-43) 
 
Staining method 
 Fixation of plant organ – The sample or seed was cut fixed in FAA solution (Formalin 
5ml + Acetic acid 5ml + 90ml of 70% Ethanol). The specimen was dehydrated after 24 hours of 
fixing. The seeds were graded with series of tertiary butyl alcohol, as per the standard method. 
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            Infiltration of the specimen - It was carried out by gradual addition of 58 – 60º C of 
melting pointed paraffin wax until Tertiary butyl alcohol (TBA) solution attained super 
saturation. The specimens were cast into paraffin blocks. 
Sectioning  
 The paraffin embedded specimens were sectioned with the help of Rotary Microtome. 
The thickness of the sections was 10 - 12µg. Dewaxing of the sections were done by customary 
procedures. The sections were stained with Toludine blue. Since toludine blue is a polychromatic 
stain, the sections were stained as per the method published by O’Brein et al. (43) The staining 
results were remarkably good. The dye rendered pink colour to the cellulose walls, blue to the 
lignified cells, dark green to subrein, violet to mucilage and blue to the protein bodies. Whenever 
necessary sections were also stained with safranin, fast green and iodine for starch.  
PHOTO MICROGRAPHS 
 Microscopic descriptions of tissues were supplemented with photo micrographs 
whenever necessary. Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observations bright field was used. 
  For the study of crystals and lignified cells, polarized light was employed. Since, these 
structures have birefringent property under polarized light they appear bright against dark 
background. Descriptive terms of the anatomical features are as given in the standard anatomy 
books. 
POWDER MICROSCOPY 
  The shade dried, powdered plant material was used for powder microscopic analysis. 
The organoleptic characters were observed and to identify the different characteristic features 
various staining reagent were used. Powder was stained with 1% phloroglucinol in 90% ethanol, 
concentrated hydrochloric acid and observed through microscope. All the lignified cells stained 
with pink colour. Calcium oxalate crystals were observed under the polarized light microscope.    
 
 
METHODOLOGY 
 
Department Of Pharmacognosy, MMC, Chennai-03. Page 22 
 
PHYSIO – CHEMICAL CONSTANTS (44-47) 
 Shade dried powdered plant material of seeds of Abelmoschus moschatus Medic. was 
used for the determination of physio chemical constants in accordance with WHO guidelines.  
DETERMINATION OF ASH VALUES 
 Ash values are helpful in determining the quality and purity of a crude drug in the 
powdered form. The residue remaining after incineration is the ash content of the drug, which 
simply represents inorganic salts, naturally occurring drug or adhering to it or deliberately added 
to it, as a form of adulteration. 
TOTAL ASH  
 Total ash is designed to measure the total amount of material remaining after ignition. 
This includes both physiological ash which is derived from plant tissue itself and non-
physiological ash which is the residue of the extraneous matter adhering to the plant surface.  
Procedure  
  Silica crucible was heated to red hot for 30 minutes and it was allowed to cool in 
desiccators. About 2gm of powdered sample was weighed accurately and evenly distributed in 
the crucible. Dried at 100 – 105°c for 1 hour and ignited to constant weight in a muffle furnace at 
600±25ºC. The crucible was allowed to cool in a desiccator. The percentage of ash with 
reference to the air dried substance was then calculated. 
Water soluble ash 
 The ash was boiled for 5min with 25ml of water. The insoluble matter was then collected 
in an ash less filter paper. It was washed with hot water and ignited for 15min at a temperature 
not exceeding 450°c. The weight of the insoluble matter was subtracted from the weight of the 
ash and the difference in weight represented the water soluble ash, the percentage of water 
soluble ash with reference to the air dried substances was calculated. 
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Acid insoluble ash  
 Acid insoluble ash is the residue obtained after boiling the total ash with dilute 
hydrochloric acid, and igniting the remaining insoluble matter. This measures the amount of 
silica present, especially as sand and siliceous earth. 
Procedure  
 To the total ash obtained, 25ml of hydrochloric acid was added, covered with a watch 
glass and boiled gently for 5min on a burner. The watch glass was rinsed with 5ml of hot water 
and these washings were added to the crucible. The insoluble matter was collected on an ash less 
filter paper by filtration and the filter paper was rinsed repeatedly with hot water until the filtrate 
is neutral and free from acid. Filter paper containing the insoluble matter was transferred to the 
crucible, dried on a hot plate and ignited to a constant weight in the muffle furnace at 450-500°C. 
The silica crucible was removed from the muffle furnace and allowed to cool in a desiccator for 
30min, and then weighed without delay. The content of acid insoluble ash was calculated. 
Sulphated ash 
 2-3gm of air-dried substance was ignited gently at first in a crucible, until the substance 
was thoroughly charred. Then the residue was cooled, moistened with 1ml of  sulphuric acid, 
heated gently until the white fumes were no longer evolved and ignited at 800±25°C, until all the 
black particles were disappeared. The crucible was allowed to cool, a few drops of sulphuric acid 
was added and heated. Then it was ignited as before, cooled and weighed. The percentage of 
sulphated ash with reference to the air- dried substance was then calculated.     
DETERMINATION OF EXTRACTIVE VALUES 
 Extractive values are useful for the evaluation of phyto constituents especially when the 
constituents of a drug cannot be readily estimated by any other means. Further these values 
indicate the nature of the active constituents present in a crude drug. 
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Determination of water soluble extractive 
 5gm of the powder was weighed and macerated with 100ml of chloroform water (95ml 
distilled water and 5ml chloroform) in a closed flask for 24 hours. It was shaken frequently for 
six hours and allowed to stand for eighteen hours. It was then filtered rapidly, taking precautions 
against loss of solvent and 25ml of the filtrate was evaporated to dryness in a tarred flat 
bottomed shallow dish. 2 ml of alcohol was added to the residue and it was dried at 105°C for 1 
hour in the hot air oven and cooled in desiccators for 30min and weighed. The process was 
repeated till a constant weight was obtained; the percentage of water soluble extractive value 
with reference to the air dried drug was calculated. 
    Water soluble extractive value = weight of the dried extract / weight of the sample taken × 100 
Determination of alcohol soluble extractive 
 5gm of the powder was weighed and macerated with 100ml 90% ethanol in a closed flask 
for 24 hours. It was shaken frequently for six hours and allowed to stand for eighteen hours. It 
was then filtered rapidly, taking precautions against loss of solvent and 25ml of the filtrate was 
evaporated to dryness in a tarred flat bottomed shallow dish. It was dried at 105°C for 1hour in a 
hot air oven. The dish was cooled in desiccator and weighed. The process was repeated till the 
constant weight was obtained. The percentage of alcohol soluble extractive value with reference 
to the air dried drug was calculated. 
      Alcohol soluble extractive = weight of the dried extract / weight of the sample taken × 100 
Determination of non volatile ether soluble extractive (fixed oil content) 
 A suitably weighed quantity of the drug was transferred to an extraction thimble and 
extracted with solvent ether or petroleum ether (Boiling Point 40 - 60°C) in a Soxhlet for 6 
hours. The extract was filtered into a tarred evaporating dish, evaporated and dried at 105°C to 
constant weight. The percentage of non volatile ether soluble extractive value with reference to 
the air dried drug was calculated. 
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Determination of volatile ether soluble extractive 
 2gm of powdered drug was accurately weighed and extracted with anhydrous diethyl 
ether in a continuous extractive apparatus for 20hours. The ether solution was transferred to 
tarred porcelain dish and evaporated spontaneously. Then it was dried over phosphorous pent 
oxide for 18hours and the total ether extract was weighed. The extract was heated gradually and 
dried at 105°C to constant weight. The loss in weight represents the volatile portion of the 
extract. 
Loss on drying 
 Specified quantity of the substances was taken in a previously ignited and cooled silica 
crucible and the substance was evenly distributed by gentle side wise shaking. The crucible with 
the contents was weighed accurately. The loaded crucible and the lid were placed in the drying 
chamber (105°C). The substance was heated for a specified period of time to a constant weight. 
The crucible was covered with the lid and allowed to cool in a desiccator at room temperature 
before weighing. Finally the crucible was weighed to calculate the loss on drying with reference 
to the air dried substance.   
Determination of foaming index 
 1gm of the coarsely powdered drug was weighed and transferred to 500ml conical flask 
containing 100ml boiling water. The flask was maintained at temperature 80-90°C for about 
30min. It was then cooled and filtered into a volumetric flask and sufficient water was added 
through the filtrate to make up the volume to 100ml. The decoction was poured into 10 stopper 
test tube (height 16cm, diameter 16mm) in successive portions of 1ml, 2ml, 3ml, 4ml up to 10ml 
and the volume of the liquid in each tube was adjusted with water to 10ml. The tubes were 
stoppered and shaked in a length wise motion for 15 seconds, two shakes per second. Allowed to 
stand for 15min and the height of the foam was measured. The results are assessed as follows. 
 If the height of the foam in every tube is less than 1cm, the foaming index is less than   
100. If a height of 1cm is measured in any tube, the volume of the plant material decoction in the 
tube (a) is used to determine the index. If this tube is the first or second tube in a series, prepare 
an intermediate dilution in a similar manner to obtain a more precise result. 
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 If the height of the foam is more than 1cm in every tube, the foaming index is over 1000. 
In this case repeat the determination using a new series of dilution of the decoction in order to 
obtain a result. Calculate the foaming index using the following formula: 
                                      Foaming index = 1000/a 
 Where, a = the volume in ml of the decoction used for preparing the dilution in the tube 
where foaming to a height of 1cm is observed. 
Determination of swelling index  
 The swelling index is the volume in ml occupied by the swelling of 1gm of plant material 
under specified conditions. A specified quantity of the plant material were previously reduced to 
the required fineness was accurately weighed and transferred into a 25ml glass stoppered 
measuring cylinder. The internal diameter of the cylinder should be about 16mm, the length of 
the graduated portion about 125mm, marked in 0.2ml divisions from 0 to 25ml in an upward 
direction. Unless otherwise indicated in the test procedure, add 25ml of water and shake the 
mixture thoroughly every 10min for 1hour, allowed to stand for 3 hours at room temperature. 
The volume in ml occupied by the plant material was measured including any sticky mucilage. 
Calculate the mean value of the individual determination, related to 1gm of plant material.  
QUALITATIVE AND QUANTITATIVE ESTIMATION OF HEAVY METALS AND 
INORGANIC ELEMENTS 
(48, 49) 
 
Plant minerals play a vital role in metabolism. Presence of elements vary with the soil, 
climate conditions etc. There are essential and non essential elements which may be beneficial or 
harmful to living things. Non essential elements like lead, arsenic, cyanide, chromium, cadmium, 
aluminium, silver bring about toxic effects resulting in intoxification. Hence, qualitative and 
quantitative estimation of inorganic elements in the plant Abelmoschus moschatus Medic. were 
carried out. 
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QUALITATIVE ANALYSIS OF INORGANIC ELEMENTS AND HEAVY METALS 
(48)
 
 To the ash of the drug material 50%v/v hydrochloric acid was added and kept for 1 hour. 
It was filtered and the filtrate was used for the following tests. 
Aluminium: White gelatinous precipitate of aluminium hydroxide is formed on addition of 
ammonia solution. It is slightly soluble in excess of the reagent. The precipitate dissolves readily 
in strong acid and base, but after boiling it becomes insoluble.   
Arsenic:  Arsenious salts in neutral solution react with solution of copper sulphate to form green 
precipitate (scheele’s green) which on boiling gives a red precipitate of cupric oxide.  
Borate: The mixture obtained by the addition of sulpuric acid and alcohol (95%) to a borate 
when ignited, burns with flame tinged with green. 
Calcium: Solution of calcium salts, when treated with ammonium carbonate solution, yield a 
white precipitate after boiling and cooling the mixture (it is insoluble in ammonium chloride 
solution). 
Carbonate: Carbonate, when treated with dilute acid effervescence, liberating carbon dioxide 
which is colourless and produces a white precipitate in calcium hydroxide solution. 
Chlorides: Chlorides, when treated with silver nitrate solution, yield a white crude precipitate 
which is insoluble in nitric acid, but soluble after being well washed with water, in diluted 
ammonia, from which it is re precipitated by the addition of nitric acid. 
Copper: An excess of ammonia, added to a solution of a cupric salt, produces first a bluish 
precipitate and then a deep blue coloured solution. 
Iron: Solution of ferric salts, when treated with potassium ferrocyanide solution, yields an 
intense blue precipitate which is insoluble in dilute Hcl. 
Lead: Strong solution of lead salts, when treated with HCL, yield a white precipitate. Which is 
soluble in boiling water and is re deposited as crystals when the solution is cooled. 
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Magnesium: Solution of magnesium salts, when treated with ammonium carbonate solution and 
boiled, yield a white precipitate, but yield no precipitate in the presence of ammonium chloride 
solution. 
Mercury: Solution of mercury salts, when treated with sodium hydroxide solution, yields a 
yellow precipitate. 
Nitrate: With solution of ferrous sulphate no brown colour was observed but if sulphuric acid is 
added (slow from the side of the test tube), a brown colour is produced at the junction of two 
liquids, indicating the presence of nitrates. 
Phosphate: Solution of phosphate when treated with silver nitrate with dilute ammonia solution 
and in dilute nitric acid yield yellow precipitate of normal silver ortho phosphate (distinction 
from meta and pyrophosphate) solution. 
Potassium: Moderately strong potassium salts, which have been previously ignited to remove 
ammonium salts, when treated with perchloric acid (60%) yield a white crystalline precipitate. 
Silver: Solution of silver salts, when treated with potassium iodide solution yield a cream 
coloured precipitate which is insoluble in dilute ammonia solution and in nitric acid. 
Sulphates: Solution of sulphates, when treated with lead acetate solution yields a white 
precipitate which is insoluble in ammonium acetate solution and in sodium hydroxide. 
QUANTITATIVE ESTIMATION OF INORGANIC ELEMENTS: 
(50)
 
Inductive coupled plasma-Optical emission spectroscopy (ICP-OES)  
         It is an excellent multi-element technique with relatively good sensitivity and selectivity 
when configured correctly. This technique utilizes the plasma as an ion source or light emission 
source are capable of producing values. 
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QUANTITATIVE ANALYSIS OF HEAVY METALS 
Instrumentation parameters:  
Instrument name: Inductive coupled plasma-Optical emission spectroscopy 
Instrument Model: PE Optima 5300DV ICP-OES; Optical system Dual view-axial or radial 
Detector system: Charge coupled detector, (UV-Visible detector which is maintaining at -40º C) 
to detect the intensity of the emission line. 
Light source (Torch): Positioned horizontally in the sample compartment along the central axis 
of the spectrometer optics. Changing from axial to radial viewing is a simple software command 
and is accomplished by computer control of a mirror located in the optical path. The torch 
assembly of this system comprises of two concentric quartz tubes. 
Standard alumina injector: 2.0mm inner diameter.  
Spray chamber: Scott type 
Nebulizer: Cross flow gem tip. 
Preparation of sample by acid digestion method: 
   50mg of powder was treated with acid mixture of sulphuric acid: water in the ratio of 
4:1in the Kjeldahl flask and heated continuously till the solution is colourless. The sample 
mixture was then transferred in a 25ml volumetric flask and made up to the volume with distilled 
water. Blank solution was prepared as above without sample. 
            The standards of Arsenic, Lead, Mercury and Cadmium were prepared as per the protocol 
and the calibration curve was developed for each of them. 
Detection: 
            Samples were analyzed for the detection and quantification of the calcium, sulphate, 
borate, silver, aluminium, copper, potassium, chloride by Inductively Coupled Plasma Emission 
Spectrometry. 
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7.2 PHYTOCHEMICAL STUDIES 
 Phytochemical evaluation is used to determine the nature of phyto constituents present in 
the plant by using suitable chemical tests. It is essential to study the pharmacological activities of 
the plant. It can be done by confirmation with different chromatographic techniques like TLC 
and HPTLC. Therefore a complete investigation is required to characterize the Phyto 
constituents qualitatively and quantitatively. 
Preparation of Extracts
 (51)
 
 Extraction is the preliminary step involved in the phytochemical studies. It brings out the 
metabolites into the extracting solvent depends upon its polarity. 
Extraction 
 The first step was the preparation of successive solvent extracts. The dried coarsely 
powdered sample of Abelmoschus moschatus seed (500gm) was first extracted with Hexane (60-
80°C) in Soxhlet apparatus and then with solvents of  increasing polarity like ethyl acetate and 
ethanol at 60 - 70ºC. Each extract was concentrated using rotary vacuum evaporator. The 
percentage yield, colour and consistency of these extracts were recorded and preceded for further 
detailed phyto chemical and pharmacological screening. 
PRELIMINARY PHYTOCHEMICAL SCREENING 
(52-54) 
 
The chemical tests for various Phyto constituents in the dried powder and extracts of 
seeds of Abelmoschus moschatus were carried out as described below and the results were 
recorded. 
1. Detection of Alkaloids  
 Dragendorff’s reagent : 
             The substance was dissolved in 5ml of distilled water, to this 5ml of 2M HCL 
was added until an acid reactions occurs, then 1ml of Dragendorff’s reagent was added 
and examined for an immediate formation of an orange red precipitate. 
 
 
METHODOLOGY 
 
Department Of Pharmacognosy, MMC, Chennai-03. Page 31 
 
 Mayer’s reagent: 
           The substance was mixed with little amount of dilute hydrochloric acid and 
Mayer’s reagent and examined for the formation of white precipitate. 
 Wagner’s reagent : 
            The test solution was mixed with Wagner’s reagent and examined for the 
formation of reddish brown precipitate. 
2. Detection of Glycosides  
 Borntrager’s test : 
             The powdered material was boiled with 1ml of sulphuric acid in a test tube for 
five minutes. Filtered while hot, cooled and shaken with equal volume of chloroform. 
The lower layer of solvent was separated and shaken with half of its volume of dilute 
ammonia. A rose pink to red colour is produced in the ammonical layer. 
 Modified Borntrager’s test : 
            The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% aqueous ferric chloride solution (freshly prepared) for 5 minutes, 
and shaken with equal volume of chloroform. The lower layer of solvent was separated 
and shaken with half of its volume of dilute ammonia. A rose pink to red colour is 
produced in the ammonical layer.  
 3. Detection of Steroids and Triterpenoids 
 Libermann Burchards Test: 
            The powdered drug was treated with few drops of acetic anhydride, boiled and 
cooled. Conc.sulphuric acid was added from the sides of the test tube, brown ring is 
formed at the junction of two layers and upper layer turns green which shows presence of 
steroids and formation of deep red color indicates presence of tri terpenoids. 
 Salkowski Test : 
          The extract was treated with few drops of concentrated sulphuric acid, red color at 
lower layer indicates presence of steroids and formation of yellow colored lower layer 
indicates presence of tri terpenoids. 
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4.  Detection of Flavonoids  
 Shinoda test : 
           To the solution of extract,  few piece of magnesium turnings and concentrated Hcl 
was added drop wise, pink to crimson red, occasionally green to blue color appears after 
few minutes indicates the presence of flavonoids. 
 Alkaline reagent test : 
           To the test solution  few drops of sodium hydroxide solution was added, intense 
yellow color is formed which turns to colorless on addition of few drops of dilute acid 
indicate presence of flavonoids. 
 5. Detection of Carbohydrates 
 Molisch’s test : 
              To the test solution few drops of alcoholic alpha napthol and few drops of conc. 
sulphuric acid were added through the sides of test tube, purple to violet color ring 
appears at junction. 
 Fehling’s test : 
              The test solution was mixed with Fehling’s I and II and heated and examined for 
the appearance of red coloration for the presence of sugar. 
  6. Detection of Phenols  
 Ferric chloride test : 
               A small quantity of substance were dissolved with 2ml distilled water and a few 
drops of 10% aqueous ferric chloride solution was added and observed for appearance of 
blue or green color. 
  7. Detection of Proteins  
 Biuret test : 
The sample was treated with 5-8 drops of 10% w/w copper sulphate solution, 
violet color is formed.  
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8. Detection of Tannins 
 Lead acetate test : 
                The test solution was mixed with basic lead acetate solution and examined for 
formation of a white precipitate. 
 Ferric chloride test : 
                A few drops of 5% aqueous ferric chloride solution was added to 2ml of an 
aqueous extract of the drug and examined for the appearance of bluish black color. 
  9. Detection of Saponins  
               A drop of sodium bicarbonate solution was added to the sample and the mixture 
was shaken vigorously and left for 3 minutes. Development of any honey comb like froth 
was examined. 
   10. Detection of Gum and Mucilage 
               Small quantities of test substances was dissolved in 5 to 10ml of acetic 
anhydride by means of heat, cooled and add 0.05ml of concentrated sulphuric acid; it is 
examined for the formation of bright purplish red color. 
    11. Detection of fixed oils and fats: 
                Small quantities of extracts were pressed between two filter papers. An oily 
stain on filter paper indicates the presence of fixed oils and fats. 
FLUORESCENT ANALYSIS 
(55, 56)
 
 Fluorescence analysis was carried out in day light and in UV light. The leaf powder and 
extracts were treated with different solvents and the fluorescence was observed in day light and 
in near and far UV light.    
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QUANTITATIVE ESTIMATION OF TOTAL PHENOLIC AND TOTAL FLAVONOID 
CONTENT 
(57, 58, 59)
 
Total phenolic content (Folin – Ciocalteu’s assay) 
 Total phenolic content of the extracts were determined using Folin –Ciocalteu’s assay. 
0.5ml extract solutions were mixed with 2.5ml of 10 fold diluted Folin Ciocalteu’s reagent and 
2.5ml of 7.5% sodium carbonate. After incubation at 40°c for 30 minutes, the absorbance of the 
reaction mixtures was measured at 765nm in a spectrophotometer. Three replicates were made 
for each test sample. Gallic acid was used as a standard and total phenolic content of the extract 
was expressed in mg of Gallic acid equivalents (mg GAE/g extract).  
Total Flavanoid content 
 Total flavanoid content was determined by calorimetric method, using quercetin as a 
standard. The test samples were individually dissolved in DMSO. Then the sample solution (150 
µl) was mixed with 150 µl of 2% aluminium chloride. After 10min of incubation at ambient 
temperature, the absorbance of the supernatant was measured at 435nm using spectrophotometer. 
Three replicates were made for each test sample. The total flavanoid content was expressed as 
quercetin equivalent in mg/gm extract (mg QRT/gm extract). 
CHROMATOGRAPHY 
(60-63)
 
 Chromatography methods are important analytical tool in the separation, identification 
and estimation of components present in the plant. 
THIN LAYER CHROMATOGRAPHY 
Principle 
              Thin layer chromatography is a technique used for the separation, identification and 
estimation of single or mixture of components present in the various extracts. It is reliable 
technique in which solute undergoes distribution between two phases, stationary and mobile 
phase. The separation is mainly based on the differential migration that occurs when a solvent 
flows along the thin layer of stationary phase. This may be achieved by partition and adsorption 
depending on stationary phase used. 
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TLC Plate Preparation 
 The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was mixed with 
85ml of water to prepare homogenous suspension and poured in the spreader. 0.25mm thickness 
of plates was prepared, air dried until the transparency of the layer disappeared, then dried at 
110°C for 30 minutes and kept in desiccators. 
Selection of mobile phase 
 Solvent mixture was selected on the basis of the phyto constituents present in each 
extract. Factors such as nature of components, stationary phase, mobile phase, polarity, influence 
the rate of separation of constituents. From the vast analysis, best solvent was selected which 
showed good separation with maximum number of components.   
HPTLC- FINGERPRINT PROFILE 
 HPTLC is one of the versatile chromatographic method which helps in the identification 
of compounds and thereby authentication of purity of herbal drugs. The time required in this 
method for the demonstration of most of the characteristic constituents of a drug is very quick 
and short. In addition to qualitative detection, HPTLC also provides semi-quantitative 
information on major active constituents of a drug, thus enabling an assessment of drug quality.   
 HPTLC serves as a convenient tool for finding the distribution pattern of phyto 
constituents which is unique to each plant. The fingerprint obtained is suitable for monitoring the 
identity and purity of drugs and for detecting adulteration and substitution. HPTLC technique is 
helpful in order to check the identity, purity and standardize the quantity of active principles 
present in the herbal extract. 
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Instrument Conditions: 
Sample used               : Ethanol Extract 
Instrument  : CAMAG HPTLC 
HPTLC Applicator : CAMAG LINOMAT IV 
HPTLC Scanner : CAMAG TLC SCANNER II 
Sample dilution : 100mg of sample extracted with 1ml of Ethyl acetate 
Volume of injection : 20µl 
Mobile phase  : Ethyl acetate : Hexane (6:4) 
Lambda max  : 254nm 
Lamp   : Deuterium 
Stationary phase       : TLC silica gel 60 F254 (Merck) 
Equipment: 
          A Camag HPTLC system equipped with a sample applicator Linomat IV, Twin trough 
plate development chamber, TLC Scanner II. 
Chromatographic conditions: 
           The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 10 × 10cm pre-activated HPTLC silicagel 60 F254 plate. 
Samples were applied to the plate as 6mm wide band with an automatic TLC applicator Linomat 
IV with nitrogen flow (CAMAG, Switzerland), 8mm from the bottom. Densitometric scanning 
was performed on CAMAG scanner II. The plates were pre-washed with solvent ethyl acetate. 
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SELECTION OF ACTIVE EXTRACT 
 IN VITRO ANTI OXIDANT ACTIVITY 
(64, 65)
 
 There has been a lot of interest in the development of alternative medicine for memory 
impairment. Oxidative stress plays a major role in the progression of memory impairment. It 
occurs when the balances between free radicals which attack nerve cells and anti oxidants which 
protect them are lost. 
 Anti oxidants like poly phenols and flavanoids are therefore very helpful in maintaining 
the brain function and improving memory. It has become evident that flavanoids are able to exert 
neuro protective actions even at low concentration via their interactions with critical neuronal 
intracellular signaling pathways pivotal in controlling neuronal survival and differentiation, long 
term potentiation and memory. 
 Therefore it can be concluded from various studies that anti oxidants alone can also be 
helpful in enhancement of memory. 
 In vitro antioxidant activities for the extracts were carried out using the following 
methods. 
                              1. Reducing power assay 
                              2. Hydrogen peroxide scavenging assay. 
REDUCING POWER ASSAY 
                    The reducing power assay was determined according to the method of Oyaizu. 
Various concentrations of plant extracts (1ml) were mixed with 1ml of 200 mmol/lt of sodium 
phosphate buffer (pH 6.6) and 1ml of 1% potassium ferricyanide. The mixture was incubated at 
50ºc for 20mins. To this 1ml of 10% tri chloro acetic acid (w/v) was added and the mixture was 
centrifuged at 2000rpm for 10mins. The upper layer  (2.5ml) was mixed with 2.5ml of deionised 
water and 0.5ml of fresh ferric chloride (0.1%). The absorbance was measured at 700nm. A  
higher absorbance value indicates a higher reducing power. 
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HYDROGEN PEROXIDE SCAVENGING ASSAY 
                  The ability of the extracts to scavenge hydrogen peroxide was determined according 
to the method of Ruch. A solution of Hydrogen peroxide (2mmol/l\lt) was prepared in phosphate 
buffer (PH 7.4). Various concentrations of extracts (10-100µg/ml) were added to hydrogen 
peroxide solution (0.6ml).  Absorbance at 230nm was determined after 10min against a blank 
solution containing phosphate buffer without hydrogen peroxide. 
                        % scavenging activity = Abs (control) - Abs (standard) / Abs (control) × 100  
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7.4 PHARMACOLOGICAL STUDIES 
IN-VIVO MEMORY STRENGTHENING ACTIVITY  
In in-vitro method, the ethanolic extract showed potent anti oxidant activity which was 
comparable with the standard than ethyl acetate extract. Hence Ethanolic extract was selected for 
in-vivo study.  
 Materials and Methods 
Plant extract 
             Ethanolic extract of seeds of Abelmoschus moschatus Medic. 
Drugs and Chemicals   
 0.1M Phosphate buffer 
 Sodium Hydroxide 
 5,5’-dithiobis nitro benzoic acid (DTNB) 
 Acetyl thio choline iodide 
Preparation of drug solutions 
                 DTNB was prepared using 0.1M phosphate buffer. Acetyl thio choline iodide was 
dissolved in 1 ml of distilled water. 
 
 
Animal selection and procurement 
                 Healthy young Swiss-Albino mice (weighing about 20-30gm) were procured from the 
Madras Medical College animal house. The animals used for the entire study was approved by 
the Institutional Animal Ethical Committee which is certified by the Committee for the purpose 
of control and supervision of experiments on animals, India. 
Approved CPCSEA Registration No: 10/243/CPCSEA           Dated: 22/11/13. 
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                   The procured animals were kept in a clean, dry polycarbonate cages and maintained 
in a well-ventilated animal house. The temperature of experimental animal room was maintained 
at 22ºC (± 3ºC) and the relative humidity was maintained from 50-60%. Lighting was artificially 
maintained for 12hrs dark and 12hrs light. All the animals were kept in the cages for at least 
5days prior to dosing for acclimatization to the laboratory conditions. The animals were fed with 
standard pellet diet and water was given ad libitum. Before starting the dose, the animals were 
fasted overnight but allowed to access water. 
Acute oral toxicity studies 
(66)
 
                The acute oral toxicity study was carried out for ethanolic extract using OECD 
guidelines 423 (Organization of Economic Co-operation and Development). A single dose of 
2000mg/kg of the extract p.o was given and this was used as a starting dose. After oral 
administration, the animals were observed every 1 hour for 24 hrs to assess the general 
behavioral changes and mortality. They were further observed for 72 hrs for toxic symptoms and 
mortality. After 72hrs, no toxic signs were observed. So, 1/10
th
 and 1/5
th
 of the dose (200 and 
400mg/kg) were selected for this study.  
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                                                 Figure 7.Acute oral toxicity studies 
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EXPERIMENTAL DESIGN 
MEMORY STRENGTHENING ACTIVITY  
 Effect on Transfer Latency  
 Estimation of brain Acetyl cholinesterase level. 
Method: Elevated plus maze model 
Animals: Swiss albino mice 
Grouping of animals 
Animals were divided into 5 groups of six animals each. 
 Group I: Vehicle control- Distilled water administered orally for 7days, after 90min of 
administration, Transfer latency (TL) was recorded. Retention of learned task was examined 
after 24hrs. 
 Group II: Diazepam (1mg/kg) was injected before training. TL was recorded after 45min 
of injection. Retention was examined after 24hrs. 
 Group III: Piracetam (200mg/kg) was injected for 7days and on the 7
th
 day after 90min of 
drug administration, diazepam (1mg/kg) was given i.p. TL was recorded after 45min of injection 
and after 24hrs. 
 Group IV: Test drug I (200mg/kg) was given orally for 7 days and on 7
th
 day after 90min 
of drug administration, diazepam (1mg/kg) was given i.p. TL was recorded after 45min of 
injection and after 24hrs. 
 Group V: Test drug II (400mg/kg) was given orally for 7 days and on 7
th
 day after 90min 
of drug administration, diazepam (1mg/kg) was given i.p. TL was recorded after 45min of 
injection and after 24hrs.   
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Elevated plus maze model 
(67, 68)
 
 
  Figure 8.Elevated plus maze model 
 The elevated plus-maze consisting of two open arms (16×5cm) and two enclosed arms 
(16×5×12 cm) was used. The maze was elevated to height of 25cm. Mice were placed 
individually at the end of an open arm facing away from central platform and the time taken to 
move from the end of the open arm to either of closed arm  was recorded(Transfer Latency, TL). 
If the animal did not enter into one of the enclosed arms within 90sec, it was gently pushed into 
one of the two enclosed arms the TL was assigned as 90sec. The mice was allowed to explore the 
maze for another 10sec and then returned to its home cage. Retention of this learned task was 
examined after 24hrs, after the first day trial (i.e. on 8
th
 day) 
 On the 9
th
 day animals in all the groups were sacrificed by cervical dislocation and the 
brains were removed and used for the estimation of Acetyl cholinesterase, Malondialdehyde and 
Reduced Glutathione. 
PREPARATION OF BRAIN HOMOGENATE 
 The brains of the animals were removed quickly and placed in ice cold saline. The tissues 
were weighed and homogenized in 0.1M phosphate buffer (pH-8) and the brain homogenate was 
used for the estimation of Brain AchE level. 
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 Neurotransmitter plays a main role in maintaining normal function and behaviour of 
brain. Acetylcholine is one of the most important neurotransmitter in the brain. It plays a large 
role in learning and memory. An imbalance in acetylcholine can lead to learning and memory 
problems. 
 Estimation of Brain Acetyl cholinesterase level 
(69, 70) 
 
Estimation of brain AchE level provides a relatively easy and valuable assessment of 
cholinergic function. The method of AchE activity estimation is popularly known as Elman’s 
method named after George Ellman who developed this method in 1961(Ellman et al., 1961).
 
 
The esterase activity was measured by providing an artificial substrate, acetylthiocholine 
(ATC). Thiocholine released because of the cleavage of ATC by AchE was allowed to react with 
the –SH reagent 5, 5’-dithiobis nitro benzoic acid, which is reduced to thio nitro benzoic acid, a 
yellow coloured anion with an absorption maxima at 412nm.
 
ASSAY PROCEDURE 
(71)
 
 0.4ml of aliquot of brain homogenate was added to a cuvette containing 2.6ml of 
phosphate buffer (0.1M) and to this 100µl of DTNB was added. 
 The contents of the cuvette were mixed thoroughly by bubbling air and absorbance was 
measured at 412nm in spectrophotometer, when absorbance reaches a stable value, it was 
recorded as the basal reading. 
 100µl of substrate (ATC) was added and change in absorbance was recorded for a period 
of 10mins at intervals of 2mins. Change in the absorbance per minute was determined. 
                     The enzyme activity was calculated using the following formula 
  R = 5.74 (10⁻⁴) ΔA/Co,    
 R = Rate in moles substrate hydrolyzed per min per gm of tissue,    
 ∆A = Change in absorbance per min,        
 Co = Original concentration of tissue (mg/ml).  
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 IN VIVO ANTIOIXDANT ACTIVITY 
 The brain homogenate was used for the estimation of 
1. Brain Malondialdehyde. 
2. Brain Reduced Glutathione  
ESTIMATION OF BRAIN MALONDIALDEHYDE 
(72, 73)
  
 Malondialdehyde, indicator of lipid per oxidation was determined as described by 
Ohkawa et al. The reaction mixture consist of 0.2ml of 8.1% sodium lauryl sulphate, 1.5ml of 
20% acetic acid (pH 3.5) and 1.5ml of 0.8% aqueous solution of thio barbituric acid was added 
to the 0.2ml of processed brain homogenate. The mixture was made up to 4ml with distilled 
water and heated at 95ºC for 60 minutes. After cooling with tap water, 5ml of n-butanol and 
pyridine (15:1v/v) and 1ml of distilled water was added and centrifuged. The organic layer was 
separated out and the absorbance was measured at 532nm using UV-Visible spectrophotometer. 
ESTIMATION OF BRAIN REDUCED GLUTATHIONE (GSH) 
(72)
 
 GSH estimation in brain homogenate was measured according to the Ellman method. 
This method is based on the development of a yellow colour when 5, 5’ di thio bis nitro benzoic 
acid (DTNB) is added to the compound containing the sulfydryl groups. To 0.5ml of brain 
homogenate, 1.5ml of 0.2ml of Tris buffer (PH-8.2) and 0.1ml of 0.01M  DTNB were added and 
this mixture was brought to 10ml with 7.9ml of methanol. The above reaction mixture was 
centrifuged at 1000 rpm for 15minutes, collect the supernatant liquid. The absorbance of 
supernatant was read in a spectrophotometer against reagent blank (without sample) at 412nm.  
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8. RESULTS AND DISCUSSION 
PHARMACOGNOSTICAL STUDIES: 
                  The results of the pharmacognostical studies are as follows. 
Organoleptic characters 
Nature  - Brownish black coarse powder 
Colour  - Brown  
Odour   - Musk like odour 
Taste  - Characteristic 
Morphological Features: 
Colour  - Grayish Brown and Blackish in colour. 
Odour   - Musk like odour on crushing the seeds. 
Appearance  - Hard seed coat. 
Shape   - Reni form 
Seed length  - 0.4 -0.5cm 
Seed width  -0.5 - 0.7cm 
 
 
Figure 9.Macroscopy of seeds 
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Microscopic features 
Transverse section of seed 
 A typical Malvaceous seed which is dicot and bitegmic (Angiosperms with two 
integuments ) 
 The seed composed of epidermis, endosperm and embryo. 
 Testa is composed of 8 – 10 layers of cells in three different zones.  
 Outer zone consist of epidermal cells which are polygonal with thickened walls. 
 Middle zone consist of tangentially elongated compact cells with brown colour pigments 
nearly 3-4 layers. 
 Inner zone is composed of colourless parenchyma cells in 2-3 cell layers. Inner zone is 
followed by Palisade like scelerides layer comprises of radially elongated cells. 
 Endosperm is single layered contain bands of pigmented cells intermitted with pockets of 
mucilaginous cells.  
 Endosperm is followed by gland dotted embryo with folded cotyledons. 
MICROSCOPIC FEATURES OF THE SEEDS 
TRANSVERSE SECTION OF THE SEED 
Testa shows three different zones (Outer zone, Middle zone, Inner zone) 
 
    Figure 10. T.S of seed 
Inner Zone Middle Zone Outer Zone 
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   Figure 11.Palisade like Sclereid layer (scl) 
 
 
    Figure 12.Inner zone of the seed 
Scl 
Inner Zone 
RESULTS AND DISCUSSION 
 
Department Of Pharmacognosy, MMC, Chennai-03. Page 49 
 
 
 
   Figure 13.Inner zone of testa 
 
  
  Figure 14. Endosperm layer contains pigmented cells (En) 
 
Testa 
En 
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 Figure 15. Middle zone consist of cells with brown colour pigment 
 
 
  Figure 16.Embryo with folded cotyledons 
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   Figure 17.Single layered Endosperm cells (En) 
 
 
 
  Figure 18.Outer zone with Polygonal epidermal cells (Ep) 
En 
Ep 
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POWDER MICROSCOPY 
                The powder microscopy of seeds of Abelmoschus moschatus Medic. showed the 
presence of sclerenchyma, mucilage cells, parenchyma and oil globules. 
 
Figure 19.Scelrenchyma cells 
 
Figure 20.Mucilage cells 
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Figure 21.Testa 
 
 
 
Figure 22.Parenchyma and sclerenchyma cells 
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Table 2.The Physicochemical analysis of the seeds of Abelmoschus moschatus 
Medic.  
S.NO PHYSIO-CHEMICAL CONSTANTS 
 
RESULTS (%w/w) 
I ASH VALUE 
 
1. Total ash 
 
9.66±1.53 
2. Water soluble ash 
 
6.83±0.36 
3. Acid insoluble ash 
 
7.56±0.75 
4. Sulphated ash 
 
10.95± 0.41 
II EXTRACTIVE VALUE 
 
1. Water soluble extractive 
 
8.35±0.41 
2. Alcohol soluble extractive 
 
7.95±0.56 
3. Ether soluble extractive 
 
4.61±0.61 
4. Non volatile ether soluble extractive 
 
4.31±0.59 
III Loss on drying 
 
2.50±0.78 
IV Crude fibre content 
 
11.5±0.89 
V Foaming index 
 
<100 
VI Swelling index 
 
NIL 
 
Values are expressed as Mean ± SD, n=3 
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INORGANIC ELEMENTS AND HEAVY METAL ANALYSIS 
       Qualitative and quantitative estimation of inorganic metals were analyzed using Inductive 
coupled plasma analysis method and the results were tabulated as follows. 
      Table 3.Qualitative estimation of inorganic elements of Abelmoschus moschatus Medic. 
S.No INORGANIC ELEMENTS 
 
OBSERVATIONS 
1. Aluminium 
 
+ 
2. Chloride 
 
+ 
3. Copper 
 
+ 
4. Calcium 
 
+ 
5. Iron 
 
- 
6. Borate 
 
+ 
7. Potassium 
 
+ 
8. Carbonate 
 
- 
9. Sulphates 
 
+ 
10 
 
Silver + 
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Table 4.Quantitative estimation of inorganic elements of Abelmoschus 
moschatus.  
S.NO INORGANIC ELEMENTS 
 
TOTAL AMOUNT 
(%W/W) 
1 Calcium 
 
0.57 
2 Sulphate 
 
1.48 
3 Borate 
 
0.96 
4 Silver 
 
0.26 
5 Aluminium 
 
1.68 
6 Copper 
 
1.28 
7 Potassium 
 
2.20 
8 Chloride 
 
1.46 
Quantitative estimation of Heavy metals by ICP OES method 
           The quantification of the individual heavy metals was analyzed for the powdered mixture 
of Abelmoschus moschatus Medic. by ICP-OES technique the following metals  like arsenic, 
lead, cadmium were detected and quantified, results are given in the following table 
Table 5.Quantitative estimation of Heavy metals 
 The above observation showed that the material is within the limits as per WHO standard 
and it is safe to consume internally. 
 
S.No Element  Results (ppm) Specification 
 
1. Mercury      Not detected Not more than 0.5ppm 
 
2. Arsenic        0.084 Not more than 5.0ppm 
 
3. Lead        0.045 Not more than 10ppm 
 
4. Cadmium        0.041 Not more than 0.3ppm 
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DISCUSSION  
 Pharmacognostical studies play a key factor in establishing the authenticity of the plant 
material. The botanical identity of the seed was established by examining its anatomical features. 
           Abelmoschus moschatus Medic is the sole number of its genus and is closely related to 
temperate family Malvaceae. The anatomical examination of Abelmochus moschatus seeds 
exhibited important microscopical features like endosperm, embryo and parenchymatous cells. 
 Testa showed three zones like outer zone, middle zone and inner zone. The outer zone 
consists of epidermal cells which are polygonal with thickened walls. Middle zone consist of 
tangentially elongated compact cells with brown colour pigments, Inner zone consist of 
colourless parenchyma. 
 Powder microscopy showed the presence of parenchyma, sclerenchyma and mucilage 
cells, indeed these features can be employed for inter specific identity of drugs. 
             Physiochemical parameters are mainly used in judging the purity and quality of the 
powdered drug. Ash values of a drug give an idea of the earthy matter or inorganic elements and 
other impurities present along with the drug. 
              Ash values are mainly used in judging the purity and quality of the drug is the indicative 
of contamination, substitution and adulteration. The total ash usually consists of carbonate, 
phosphate and silicates. Total ash was found to be 9.66±1.53%w/w. The acid insoluble ash 
indicates contamination with siliceous materials like earth and sand. The value was found to be 
7.56±0.75%w/w. The value of water soluble ash was found to be 6.83±0.35%w/w. Sulphated ash 
is obtained by treatment with dil. sulphuric acid where the oxides are converted to sulphates. The 
value was found to be 10.95±0.41%w/w. 
             The alcohol soluble and water soluble extractives were found to be 7.95%w/w and 
8.35%w/w respectively. Ether soluble extractive was found to be 4.61%w/w. The alcohol soluble 
extractive value indicates the presence of considerable amount of polar organic salts present in 
the plant. These constants would help to identify and to standardize the plant by future 
researchers. 
              Loss on drying determines the amount of water and volatile matters present in a sample. 
The loss on drying was found to be 2.50%w/w. The seed powder showed absence of foaming 
index and swelling index.   
             The qualitative analysis of heavy metals and in organic elements were carried out. The 
heavy metals are present within the limits. The percentage compositions of different inorganic 
elements were determined. The presence of inorganic elements like calcium, sulphate, borate, 
silver, aluminums, copper, potassium and chloride was found to be 0.57, 1.48, 0.96, 0.26, 1.68, 
1.28, 2.20 and 1.46%w/w respectively. 
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              The detailed pharmacognostical studies on the seeds of Abelmoschus moschatus Medic 
provides information on the standardization parameters and physiochemical parameters which is 
essential for the identification of raw material and also used to differentiate the plant from its 
adulterants and substitutes. 
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PHYTOCHEMICAL STUDIES 
The results of Phytochemical studies are as follows 
Table 6.Percentage yield of successive extracts of seeds of  
Abelmoschus moschatus Medic. 
S.NO EXTRACT METHOD  
OF EXTRACTION 
 
 
PHYSICAL 
NATURE 
COLOUR YIELD 
(%W/W) 
 
1. Hexane 
 
 
 
 
 
 
 
Continuous Hot 
percolation method 
using Soxhlet 
apparatus 
Oily liquid Yellowish 
brown 
5.2 
 
 
2. Ethyl acetate 
 
 
 
Semisolid Brown in 
colour 
4.5 
 
 
3. Ethanol 
 
 
 
semisolid Dark brown in 
colour 
5.3 
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Table 7.Qualitative Phytochemical analysis  
S.No Chemical constituents Powdered 
drug 
Hexane 
extract 
Ethyl acetate 
extract 
Ethanol 
extract 
1. Steroids 
 
      +        -       +       + 
2. Glycosides 
 
       -        -        -        - 
3. Saponins 
 
       -        -        -        - 
4. Flavonoids 
 
       +        -        +        + 
5. Tannins 
 
       -        -         -        - 
6. Phenolic compounds        +        +         +        +  
 
7. Proteins 
 
       +         -        +         -    
8. 
 
Alkaloids 
 
        -         -         -        - 
9 
 
Glycosides 
 
        -         -         -        - 
10. Terpenoids 
 
        +         -         -        + 
11. Resins 
 
        +        -         +        + 
12. Nitrogenous compound         +        -         +        + 
 
13. Fats and oils 
 
        +        +          +        + 
                          
Note: + indicates presence, - indicates absence 
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Table 8.Behavior of drug powder with different chemical reagents 
 
S.NO TEST REAGENT REACTION RESULT 
 
1. Alkaloids 
 
Dragendroffs reagent No orange red ppt Absence 
 
2. Carbohydrates 
 
Fehlings I and II No red colour Absence 
 
3. Flavonoids 
 
Lead acetate solution Intence yellow 
colour 
Presence 
 
4. Glycosides 
 
Anthrone + Sulphuric acid No reaction Absence 
5. Gum 
 
Hcl+ Benedicts test No reaction Absence 
6. Resins 
 
Acetone No reaction Absence 
7. Phenols 
 
5% ferric chloride Formation of 
blakish violet to 
pinkish red 
Presence 
8. Proteins 
 
Picric acid Violet colour Presence 
9. Saponins 
 
Shake with water No frothing Absence 
10. Steroids 
 
Acetic anhydride + 
sulphuric acid 
 Presence 
11. Tannins 
 
Lead acetate test No reaction Absence 
12. Terpenoids 
 
Tin + Thionyl chloride Pink red colour Presence 
13. Fats and oils 
 
Saponification test  Presence 
14. Mucilage 
 
Rhuthenium test No reaction Absence 
 
Note: + indicates presence, - indicates absence 
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QUANTITATIVE ESTIMATION OF PHYTOCONSTITUENTS 
TOTLA FLAVANOID CONTENT 
Table 9. Determination of Total Flavanoid content  
  S.No Concentration of standard 
solution(µg/ml) 
Absorbance(765nm) 
1. 2 0.07 
2. 4 0.10 
3. 6 0.13 
4. 8 0.16 
5. 10 0.20 
6. Ethyl Acetate 0.12 
7. Ethanol 0.17 
 
Figure 23.Standard calibration curve for determination of total Flavanoid Content 
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TOTAL PHENOLIC CONTENT 
Table 10.Determination of Total Phenolic Content  
 
S.No Concentration of standard 
solution(µg/ml) 
Absorbance 
1. 20 0.13 
2. 40 0.16 
3. 60 0.19 
4. 80 0.22 
5. 100 0.25 
6. Ethyl Acetate 0.15 
7. Ethanol 0.17 
 
 
Figure 24.Standard Calibration curve for determination of total Phenolic content 
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Table 11.Quantitative estimation of phytoconstituents 
Total Phenolic and Flavanoid content of extracts of Abelmoschus moschatus  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No EXTRACT TOTAL FLAVANOID       
CONTENT 
TOTAL PHENOLIC 
CONTENT 
1. Ethyl acetate 5.250µg/mg                       
 
50.25 µg/mg 
2. Ethanol  8.375µg/mg                       
 
70.42 µg/mg 
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Table 12.Fluorescence characteristic of powdered samples of 
Abelmoschus moschatus at short UV and long UV. 
 
S.NO TREATMENT DAY LIGHT SHORT UV (254nm) 
 
LONG UV (366nm) 
1. Powder  
 
Light brown Brown 
 
 
Light black 
2. Powder + water 
 
Light brown Brown 
 
 
Blackish brown 
3. Powder + NaoH 
 
Brown  Blackish brown 
 
 
Brownish black 
4. Powder + Hcl 
 
Dark brown Blackish brown 
 
 
Brownish black 
5. Powder + Acetic acid 
 
Brown Dark brown 
 
 
Dark brown 
6. Powder + Alc.NaoH 
 
Dull brown Dark blackish brown 
 
 
Black 
7. Powder + Picric acid 
 
Light brown Brown 
 
 
Dark brown 
8. Powder + Sulphuric acid 
 
Dark brown Dark brownish black 
 
 
Dark brown 
9. Powder + Nitric acid 
 
Dark brown Brownish black 
 
 
Dark brown 
10. Powder + Iodine Brown 
 
Pale brown 
 
 
Black 
11. Powder + Feclз Dark brown 
 
Dark brown 
 
 
Brownish black 
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Table 13.Fluorescence analysis of various extracts of Abelmoschus moschatus 
Medic. 
 
 
S.No Extracts Day light  Short UV Long UV 
 
 
1. Hexane Yellowish brown Yellowish brown Brown 
 
2. Ethyl acetate Brown Brown Dark brown 
 
3. Ethanol Brown Brown Dark brown 
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THIN LAYER CHROMATOGRAPHY OF EXTRACTS 
 
Table 14.Thin layer chromatography of Ethyl acetate and Ethanol extract. 
 
 
                 
 
 
Figure 25, 26. TLC Profile for ethyl acetate and ethanolic extract 
 
 
 
 
S.No Extracts Solvent system 
 
No. Of  Spots Rf value 
1. 
 
 
Ethyl Acetate Ethyl acetate: Formic acid: 
Glacial Acetic acid: 
Water(100:11:11:26) 
2 0.51 
0.69 
2. 
 
 
Ethanol Ethyl acetate: Formic acid: 
Glacial Acetic acid: 
Water(100:11:11:26) 
2 0.58 
0.68 
TLC of ethyl 
acetate extract  
TLC of ethanolic 
extract  
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HPTLC Finger print Data of Ethanolic Extract of Abelmoschus moschatus Medic. 
High performance thin layer chromatography (HPTLC) finger printing was performed with the 
ethanol extract of Abelmoschus moschatus Medic. The chromatographic conditions were carried 
as detailed in material and method of this study. There were 8 peaks observed with different Rf 
Values and different heights. Percentage of areas was also obtained from the chromatogram.  
 
Table 15.Solvent system 
Extract Solvent System 
 
Ethanol Ethyl acetate : Hexane (6:4) 
 
      
 
Figure 27.TLC Profile for Ethanolic extract 
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Table 16.HPTLC profile of ethanolic extracts 
S.No Rf Height Area Lambda max 
1. 0.02 46.7 678.5 275 
2. 0.06 6.3 168.2 290 
3. 0.15 4.1 118.2 291 
4. 0.16 3.6 155.2 289 
5. 0.54 8.2 336.4 282 
6. 0.81 2.7 64.9 279 
7. 0.85 9.9 317.3 271 
8. 0.95 1.1 17.1 280 
 
 
Figure 28.HPTLC Profile of ethanolic extract 
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PHYTOCHEMICAL STUDIES 
 DISCUSSION 
                Since herbal medicines are prepared from materials of plant origin they are prone to 
contamination, deterioration and variation in composition. Hence, before proceeding to clinical 
studies, scientists need a tool to authenticate plants and also to detect their potency. 
                A lot of analytical techniques have been developed for quality control of drugs from 
plant origin. Therefore it is very important to undertake phytochemical investigations along with 
biological screening to understand therapeutic efficacy of medicinal plants and also to develop 
quality parameters. 
               In this analysis different polarity of Phyto constituents were sorted out from the 
coarsely powdered seeds of Abelmoschus moschatus Medic., by using solvents of increasing 
polarity like Hexane, Ethyl acetate and Ethanol by using successive solvent extraction. 
Successive extractive values revealed the solubility and polarity particulars of the metabolites in 
the seed powder. Percentage yield of various extracts were as follows, hexane (5.2%w/w), ethyl 
acetate (4.5gm) and ethanol (5.3gm). Ethanolic extract showed high extractive yield among other 
extracts. 
              Qualitative preliminary phytochemical analysis was performed initially with different 
respective chemical detecting agent to detect the Phyto constituent’s nature and their presence in 
each extract and powder. 
              Hexane extract showed the presence of steroids, phenols, fats and oils. Ethyl acetate 
extract showed the presence of steroids, flavanoids, proteins, resins, fats, oils and nitrogenous 
compounds. The ethanolic extract showed the presence of steroids, flavanoids, phenols, proteins, 
nitrogenous compound, Terpenoids, resins and fats and oils. 
 Quantitative estimation of flavanoids, phenols and fluorescence analysis of extracts with 
different chemical reagents were carried out. Total phenolic content and flavanoid content of 
ethyl acetate and ethanolic extract were done by calibration curve method and the values were 
found to be 5.25µg/mg and 8.37µg/mg for flavanoid content and 50.25µg/mg and 70.42 µg/mg 
for phenolic content respectively. 
                Qualitative chromatographic analysis of ethyl acetate and ethanolic extracts were done 
by using Thin Layer Chromatography to separate and identify the single or mixture of 
constituents present in each extract. The following solvents system was used to separate the 
phytoconstituents by using Ethyl acetate: Formic acid: Glacial acetic acid: Water (100:11:11:26). 
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               High performance thin layer chromatography (HPTLC) fingerprinting was performed 
with the ethanol extract of the seeds of Abelmoschus moschatus Medic. There were 8 peaks 
observed with different Rf values and different heights. Percentage of areas were also obtained 
from the chromatogram.  
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SELECTION OF ACTIVE EXTRACT 
INVITRO ANTI OXIDANT ACTIVITY 
Table 17.  Reducing Power Assay 
S.No Concentration % Inhibition 
Standard 
(Ascorbic acid) 
Ethanol Ethyl acetate 
1. 10 14.28 13.84 12.24 
2. 20 26.84 23.26 21.20 
3. 30 48.46 45.25 42.14 
4. 40 60.14 56.26 54.15 
5. 50 71.86 68.24 65.84 
 
 
 
    Figure 29.In vitro Reducing power assay 
  
S.NO GROUPS IC50 VALUE 
1. Standard 33.54 
2. Ethanol 33.60 
3. Ethyl acetate 35.43 
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HYDROGEN PEROXIDE SCAVENGING ASSAY 
Table 18. 
S.No Concentration % Inhibition 
     Standard   
 ( Ascorbic acid)  
Ethanol Ethyl acetate 
1. 10 12.95 11.84 10.61 
2. 20 24.81 23.46 21.28 
3. 30 45.62 44.18 43.59 
4. 40 57.21 55.95 53.16 
5. 50 68.28 66.21 64.18 
 
 
   Figure 30.In vitro hydrogen peroxide assay 
 
S.NO GROUPS IC50 VALUE 
1. Standard 33.54 
2. Ethanol 33.84 
3. Ethyl acetate 35.43 
DISCUSSION 
 Anti oxidant activity and memory enhancing effect are positively correlated. Hence, both 
ethyl acetate and ethanol extracts are found to posses anti-oxidant activity. 
 But compared to ethyl acetate, ethanol extract has potent anti oxidant activity as that of 
standard. So ethanolic extract was selected for further pharmacological studies.  
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PHARMACOLOGICAL ACTIVITY 
ACUTE TOXICITY STUDIES: 
 The acute toxicity studies were done by OECD guidelines 425. No mortality was 
observed following the oral administration of seed extracts even with the highest dose 
2000mg/kg body weight. So, 1/10
th
 and 1/5
th
 of this dose (200 and 400mg/kg) were considered 
as a safety dose for this study. 
 
IN VIVO ACTIVITY PHARMACOLOGICAL STUDIES: 
1. Memory strengthening activity 
2. In vivo antioxidant activity 
 
MEMORY STRENGTHENING ACTIVITY 
 Effect on Transfer Latency  
 Estimation of brain Acetyl cholinesterase level. 
 
Effect on Transfer Latency (By Elevated Plus Maze): 
 Transfer Latency (TL) of first day (on seventh day of drug treatment) reflected 
acquisition or learning behavior of animals. Whereas, TL of next day reflected retention of 
information or memory. The animals treated orally with 200mg and 400mg/kg showed 
remarkable reduction in (P<0.01) TL of 7
th
 day as well as 8
th
 day, indicating significant 
improvement in memory. Diazepam (1mg/kg) injected before training significantly increased 
(p<0.01) TL on days 7
th
 and 8
th
 day indicating impairment in learning and memory. 
 The Abelmoshcus moschatus at higher dose level (400mg/kg p.o for 7 successive days) 
successfully reversed memory deficits induced by Diazepam (p<0.01), Piracetam (used as the 
positive control) at a dose of 200mg/kg i.p also improved learning and memory in mice and 
reversed the memory impairment produced by Diazepam as expected.  
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Table19. Effect on Transfer latency 
S.NO GROUPS TL ON 7
th
 DAY 
(Time in sec) 
TL ON 8
th
 DAY 
(Time in sec) 
1. Control (Vehicle p.o) 46.83± 2.71 30.83±2.04 
 
2. Disease control 65.17±3.92** 68.50±6.12** 
 
3. Piracetam 
control(200mg/kg i.p) + 
Diazepam 
34.83±4.49** 18.00±4.56** 
4.  Test drug I(200mg/kg 
p.o) + Diazepam 
45.17±2.85** 39.83±1.60** 
5. Test drug II (400mg/kg 
p.o) + Diazepam 
40.83±3.48** 23.66±3.74* 
                   
 Values are expressed in mean ± SEM (n=6) ** denotes p<0.01 as compared to control 
group of young mice, * denotes p<0.05 as compared to control group.(One way ANOVA 
followed by Dunnett’s test) 
                                   
 
Figure 31.Transfer latency on 7
th
 and 8
th
 day 
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Estimation of Brain Acetyl cholinesterase level 
 Abelmoschus moschatus Medic at dose of 200mg and 400mg/kg p.o significantly 
(p<0.01) reduced the levels of acetyl cholinesterase as compared to Diazepam treated group by 
Elman’s method, which is considered as indicator of inhibition of Acetyl cholinesterase activity 
in mice brain after 8 days of treatment. Piracetam (200mg/kg) i.p significantly (p<0.01) reduced 
the levels of Acetyl cholinesterase and indicated in below table. 
Treatment Groups 
 
Acetyl cholinesterase level 
(µmole/min/gm of tissue) 
Control (Vehicle p.o) 3.59 ± 0.12×10
-7
 
 
Disease control(Diazepam 1mg/kg 
i.p) 
6.47± 0.14×10
-7
** 
Piracetam control(200mg/kg i.p) + 
Diazepam 
2.69± 0.09×10
-7
** 
AM (200mg/kg p.o) + Diazepam 4.75± 0.06×10
-7
** 
 
AM (400mg/kg p.o) + Diazepam 3.12± 0.02×10
-7
** 
 
                Values are expressed as Mean ± SEM, (n=6) and **denotes p < 0.01 when compared 
to control group of young mice. (One way ANOVA followed by Dunnett’s test.) 
    Table 20.Brain AchE level 
 
 
 
    Figure32. AchE inhibitory activity 
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IN VIVO ANTIOXIDANT ACTIVITY 
 Estimation of Brain Malondialdehyde content. 
 Estimation of Brain reduced Glutathione level. 
Estimation of Brain Malondialdehyde content 
 Abelmoschus moschatus at dose of 200mg/kg and 400mg/kg p.o significantly (p<0.01) 
reduced the levels of Malondialdehyde content as compared to Diazepam treated group, which is 
considered as indicator of inhibition of lipid per oxidase activity in mice brain after 8 days of 
treatment. Piracetam (200mg/kg) i.p significantly (p<0.01) reduced the levels of 
Malondialdehyde content and indicated in below table. 
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 Values are expressed as Mean ± SEM, (n=6) and **denotes p < 0.01 when compared to 
control group of young mice.(One way ANOVA followed by Dunnett’s test.) 
  Table 21.Effect of Abelmoschus moschatus (200mg, 400mg) on brain   
     Malondialdehyde level of mice. 
 
    Figure 33.Brain Malondialdehyde level 
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Brain Malondialdehyde Level 
Treatment Groups 
 
Brain Malondialdehyde content 
(unit/mg of wet tissue) 
Control (Vehicle p.o) 45.55 ± 0.12 
 
Disease control(Diazepam 1mg/kg 
i.p) 
66.57 ± 0.13** 
Piracetam control(200mg/kg i.p) + 
Diazepam 
44.46 ± 0.10** 
AM (200mg/kg p.o) + Diazepam 50.82 ± 0.05** 
 
AM (400mg/kg p.o) + Diazepam 46.36 ± 0.11** 
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Estimation of Brain Reduced Glutathione Level 
 Abelmoschus moschatus showed remarkable increase in brain reduced glutathione level 
in both Piracetam and Abelmoschus moschatus 400mg/kg treated groups. The percent decline in 
the reduced Glutathione level were 24.88% (p<0.01) and 27.47% (p<0.01) at AM 
concentration200, 400mg. 
 
 
 
 
 
 
 
 
       Table 22.Brain reduced glutathione level 
 
 
Figure 33.Brain reduced Glutathione Level  
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Brain Reduced Glutathione 
(unit/mg of wet tissue) 
Control (Vehicle p.o) 23.31 ± 0.17 
 
Disease control(Diazepam 1mg/kg i.p) 17.23 ± 0.04** 
 
Piracetam control(200mg/kg i.p) + 
Diazepam 
28.40 ± 0.12** 
AM (200mg/kg p.o) + Diazepam 
 
24.87 ± 0.11** 
AM (400mg/kg p.o+ Diazepam 27.46 ± 0.21** 
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DISCUSSION 
 The present study has been carried out to evaluate the potential of seeds of Abelmoschus 
moschatus Medic. on memory strengthening activity.  
 The ethanolic extract which showed potent anti oxidant activity was selected for the in-
vivo study. Based on the acute toxicity studies, 1/10
th
 and 1/5
th
 (200mg and 400mg) were 
selected for further in vivo studies. 
             The ethanolic extract of seeds of Abelmoschus moschatus Medic. (200 and 400mg) when 
fed with normal diet for 7days improves the memory of mice reflected by reduced TL (Transfer 
latency) values as when compared to control group (1). Furthermore the extract administration 
protected the mice from the development of memory deficits observed after diazepam treatment.   
              Biochemical estimation of different parameter as mentioned above showed the elevation 
of acetylcholine level by significant reduction of acetyl cholinesterase activity in brain.                     
    
 Furthermore plant extract decreased the increase potential of MDA level, an indicator of 
lipid per oxidation index and increased level of reduced glutathione a potential element of free 
radical scavenging cycle in the brain as compared to control as well as disease control group. 
Therefore, it appears that Abelmoschus moschatus seeds possesses the memory enhancing 
capacity in the view of its (i) AchE Inhibitory activity (ii) on the basis of its anti oxidant property 
a significant decreased in MDA level and sharp increase in anti-oxidant process by increase in 
reduced glutathione level in mice brain.    
 Hence from the above results, it is concluded that the ethanolic seed extract of 
Abelmoschus moschatus may be useful in treatment of Alzheimer’s disease. 
 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
 
Department Of Pharmacognosy, MMC, Chennai-03. Page 81 
 
9. SUMMARY AND CONCLUSION 
  The project entitled “Pharmacognostical, Phytochemical and Memory Strengthening 
activity of the seeds of Abelmoschus moschatus Medic.,(Malvaceae) has been achieved by the 
following results. 
 The literature survey showed that, only scrappy information was available on this shrub. 
With this scanty information on this plant consistent expectation of unexplored Phyto 
chemical profile and pharmacological efficacy under Malvaceae family forms the 
rationale for the study. 
 The pharmacognostical studies provide a protocol of specific distinguishing features of 
the plant which is used to differentiate it from its closely related species. 
 Morphological study has provided a characteristic identify of seed which has grayish-
brown and blackish in colour, kidney shaped, slightly compressed with shallow 
depression on both sides, marked with minute parallel ridges and furrows. 
 Anatomical studies revealed the presence of parenchyma cells, epidermal cells, 
endosperm containing oil globules and embryo. 
 Powder analysis showed the presence of Mucilage cells, parenchymatous cells, 
sclerenchyma cells, abundant endosperm cells and oil globules. 
 Varying physio chemical parameters such as ash values, extractive values, loss on drying, 
crude fibre content, swelling index and foaming index were studied. 
 Presence of calcium added up its nutritional value and could be attributed to its memory 
enhancing activity. There is no fluorescence observed in the particular species. 
 The above mentioned specific characters might offer reliable clues for the correct 
identification of this seed part in crude as well as fragmentary form and also ensure its 
differentiation from its substituent’s and adulterants. 
 Phytochemical evaluation deals with chemical analysis of the extract used for 
pharmacological screening. Qualitative preliminary phytochemical analysis was 
performed to detect the phytoconstituents nature and their presence in powder and its 
various extracts. 
 Ethyl acetate extract showed the presence of steroids, flavanoids, proteins, resins, fats 
and oils and nitrogenous compound. Whereas the ethanolic extract showed the 
presence of steroids, flavanoids, phenols, proteins, nitrogenous compound, 
terpenoids, resins and fats and oils.  
 Total phenolic content and total flavanoid content of ethyl acetate and ethanol extract 
were determined quantitatively. 
 Qualitative chromatographic analysis (TLC) was performed to identify the single or 
mixture of constituents in the extract. 
 The active extract was selected on the basis of in vitro anti oxidant activities. 
Accordingly the ethanolic extract with potential anti oxidant activity was selected for in 
vivo study. 
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 Based on the acute toxicity studies, 1/10th and 1/5th (200 and 400 mg/kg) of the maximum 
tolerated dose (2000 mg/kg B.W) were selected for the in vivo studies. 
 The ethanolic extract of the seeds of Abelmoschus moschatus Medic. was administered 
orally for seven days showed a dose dependent and significant improvement in 
memory of young mice and it also successfully reversed the memory deficits induced by 
diazepam. Furthermore a significant decreased in cholinergic transmission, lipid per 
oxidation and increase in brain reduced glutathione level in mice brain accounts for 
its multifarious beneficial effects such as memory enhancing property, anti cholinesterase 
and antioxidant property. 
 
 From the above mentioned studies it can be concluded that the pharmacognostical 
standards generated is useful for the proper identification of plant and also to differentiate 
it from its closely related species and adulterants with the support of in vitro studies and 
Phytochemical screening, the ethanolic extract was subjected to in vivo studies. The 
ethanol extract with low and high dose showed a significant memory strengthening 
activity. This may be due to one or more phytoconstituents present in it. 
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